Implications of Indian IP policy on patenting activity of pharmaceutical multinational corporations in India Online publication date: Thu, 12-May-2016
by P. Venkataraman; Gauri Bhagwat; Vasanti Deshpande; Kavita Lanke
International Journal of Intellectual Property Management (IJIPM), Vol. 8, No. 3/4, 2015
Abstract: The situation created after the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and compulsory licensing may have an impact on pharmaceutical multinational corporations (MNCs) patent filing trend in India. So, there is a need to understand the impact of intellectual property (IP) policy change in the patenting trend of pharmaceutical MNCs in India. There are no studies on the patenting trend of pharmaceutical MNCs in India specifically to their disclosed treatable diseases and product and process patent types. This study is based on patinformatics and information analysis, to establish the implications of Indian IP policy on patenting activity of pharmaceutical MNCs in India. This study correlates pre and post TRIPS patenting trend of pharmaceutical MNCs in India. This study finds that after an amendment of Indian Patent Act in compliance with TRIPS norms, MNCs have filed a number of patents in India. This study concludes that Indian pharmaceutical companies can devise the R&D strategy to alter the product by keeping a close watch on MNCs' patent filing activity on product as well as the process in other territories; this will give them a competitive edge over the global players.
Online publication date: Thu, 12-May-2016
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org